Full course description
Release Date: June 4th, 2021
Expiration Date: June 30th, 2022
This is a self-paced non-cohort based course designed to cover the basics of movement disorders for residents. This 8-week (module) course will cover diagnosis and management of common movement disorders including approach and workup of of common movement disorder presentation at a Resident level.
This course is intended to enhance Movement Disorders (MD) training using blended learning, the most modern teaching methodology, including recorded lectures, reading assignments, tasks, quizzes and formative assessments.
This course is primarily intended for Neurology Residents but can be useful for Residents in Neurosurgery, Psychiatry, Physical Medicine and Rehabilitation, Internal medicine and Family Medicine.
Although the course is not specifically designed for General physicians, they can still benefit from the course though lot of emphasis is given on concepts and details but a practical hands-on case based approach is used at many places. General Neurologist may benefit from this course but is not an in-depth review of Movement Disorders which is primarily covered in our Mini-fellowship in Movement Disorders (an annual 6-months cohort based course, find details on UNMC Neurology webpage).
This course is not intended for Medical Students (who may benefit from our course on Neurology for Primary care, Advanced Neurological examination and Introduction to Neurology Residency), as a basic understanding of neurology may be required and many advanced concepts are discussed. We do not discourage any enthusiastic interested medical student from signing up.
- Impart knowledge and skills that will be helpful in diagnosing and treating patients with movement disorders.
- Close the gap in sub-specialty education where it exists internationally.
- This course promises to increase your professional development globally.
At the conclusion of this course, the participant should be better able to
- Examine patients with movement disorders
- Determine movement disorder treatment options
- Employ specialized skills in movement disorders
The course is designed as an 8-week course divided into 8 modules. However this self-paced course can be completed in much shorter time by completing modules early such as on daily basis. We do not require the course to be completed in 8 weeks.
This is a non-CME course with a Certificate of Completion offered at the end of the course without any CME credits.
Module 1: Tremors and Essential Tremor
Module 2: Parkinson Disease I (diagnosis and pathophysiology)
Module 3: Parkinson Disease II (Medical and Surgical Management)
Module 4: Ataxia and Spasticity
Module 5: Neuroanatomy and Dystonia
Module 6: Atypical Parkinsonism
Module 7: Chemodenervation with botulinum toxin
Module 8: Chorea, HD, Tics and Tourette syndrome
Additional Bonus Topics are accessible on successful completion of all requirements of each module and listed below
Bonus Topics: Handwriting analysis in Movement Disorders; Vascular and Unusual Movement Disorders; Examination techniques for PD-plus syndromes; Invisible movement disorders; Neuroimaging for Movement Disorders; Paroxysmal Dyskinesias; Myoclonus
A confirmation email containing instructions to the course (UNMC Catalog) will be sent to the email address you provided during registration. Keep the confirmation email open during the UNMC Catalog enrollment process.
All speakers, planning committee members and others in a position to control continuing education content participating in a UNMC accredited activity are required to disclose relationships with commercial interests. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Disclosure of these commitments and/or relationships is included in these activity materials so that participants may formulate their own judgments in interpreting its content and evaluating its recommendations.
This activity may include presentations in which faculty may discuss off-label and/or investigational use of pharmaceuticals or instruments not yet FDA-approved. Participants should note that the use of products outside currently FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for FDA-approved indications.
All materials are included with the permission of the authors. The opinions expressed are those of the authors and are not to be construed as those of the UNMC.
The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.
Faculty and Planning Committee Disclosures
Danish Bhatti, MD, FAAN
- Advisory Board: Acadia Pharmaceuticals; Adamas Pharmaceuticals, Inc.; Acorda Therapeutics, Inc.; Merz; AbbVie
- Training/education: Allergan Pakistan; PharmEvo Pakistan; Adamas Pharmaceuticals; Teva Neurosciences
Danish Bhatti, MD, FAAN
John Bertoni, MD, PhD FAAN
Erin Cameron-Smith, MD
Sarah Doss, MD
Deepmala Nandanwar, MD
Mara Seier, MD
Kiel Woodward, MD
If you have any questions about this course, please contact the following:
- Module content: Danish Bhatti, firstname.lastname@example.org
- Canvas Catalog: Julie Gregg, email@example.com